Forging Towards a New Horizon in Diabetes

The definitive medical forum in the Western Pacific Region on the care, prevention and treatment of diabetes

Hosted by the Diabetic Society of Singapore, the 10^th International Diabetes Federation-Western Pacific Region (IDF-WPR) Congress 2014 will be held from 21 to 24 November in Singapore.  This event will feature expert speakers and interactive workshops, providing valuable insights for healthcare professionals. Attendees will also have the opportunity to learn about the latest advancements in diabetes management, including the use of nursing SOAP note writers to enhance patient care documentation.

Why you must attend this meeting:-

1. Update yourself on knowledge of diabetes, learn new technological and pharmacological developments and better understand some of the controversies in diabetes care and management.
2. Attend pre-congress workshops on Diabetes Education, Continuous Subcutaneous Insulin Infusion and the latest findings on Bariatric Surgery.
3. Participate and discuss with basic scientists and researchers in the region and beyond on their seminal papers and studies in our extensive poster and oral presentation sessions.

News & Updates

Key International Speakers

The Congress brings together distinguished speakers around the world with the aim to improve levels of clinical and basic research on diabetes in the region. These include:-

	- Mobile connectivity and diabetes eHealth - "Actionable" SMBG for patients using insulin		Emerging data about ARNT and other transcription factors in gene expression and islet dysfunction in type 2 diabetes and gestational diabetes
	David Kerr, MD, FRCPE Director of Research and Innovation William Sansum Diabetes Center		Jenny Gunton Chair of Medicine, University of Sydney, Westmead Hospital President, Australian Diabetes Society
	- The usefulness of glucose and lipid control in nephropathy and retinopathy - Using HbA1c to diagnose diabetes is neither helpful, nor is it accurate		An Asian diabetes phenotype, or a phenotype in transition? Juliana Chan Chair Professor, Department of Medicine and Therapeutics Director, Hong Kong Institute of Diabetes and Obesity Co-director, IDF Centre of Education, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
	Jonathan Shaw Associate Director Health Services of Baker IDI Heart and Diabetes Institute
	- The evolving paradigm in T2DM treatment with contemporary and complimentary therapeutic strategies - DPP4 inhibitors: the CV outcomes trials		National diabetes care models: perspective from ASEAN countries
	Lawrence A. Leiter, MD, FRCPC, FACP, FAHA Professor of Medicine and Nutritional Sciences, University of Toronto		Pongamorn Bunnag Assistant Professor Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University
	Type 1 diabetes mellitus in preschool children Ragnar Hanas, MD, PhD Associate Professor The Sahlgrenska Academy University of Gothenburg Institute of Clinical Sciences		- Optimising glycemic control to protect renal and cardiovascular complications of type 2 diabetes- Findings from ADVANCE-ON - National diabetes care models: perspective from ASEAN countries
			Siew Pheng Chan, MBBS (Malaya), FRCP (Edinburgh), AM (Malaya) Visiting Professor Senior Consultant Endocrinologist Endocrine Unit, Department of Medicine University of Malaya Medical Centre, Kuala Lumpur, Malaysia
	- Ethnic differences in genome-wide association studies - Is diabetes truly still a coronary artery disease equivalent?		- The epigenome and its role in diabetes - Adipose tissue inflammation and B regulatory cell dysfunction
	Tai E Shyong Senior consultant, National University Hospital Associate Professor, Yong Loo Lin School of Medicine and Saw Swee Hock School of Public Health, National University of Singapore Associate Professor, Duke-National University of Singapore Graduate Medical School		Takashi Kadowaki, MD, PhD Professor of Diabetes and Metabolic Diseases University of Tokyo
	- Epidemic obesity and the rise of type 2 diabetes in Asia - DPP-4 Inhibitors: Have We Optimized Their Role in the Treatment of Patients With Type 2 Diabetes?		Adiponectin, FGF21 and metabolic homeostasis
	Yoon Kun-Ho Professor of Department of Endocrinology and Metabolism, Seoul St. Mary’s Hospital, The Catholic University of Korea		Xu Aimin, PhD, MD Professor of Medicine, Director of State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong

Click here to view the scientific programme now!